Shares in MaaT Pharma (Euronext: MAAT), a French microbiome company in oncology, closed 25% higher Tuesday. The company ...

German drugmaker STADA Arzneimittel has reported record earnings on revenues growth in its financial first quarter.

Shanghai-based Mabwell Bioscience (SH: 688062) has secured approval from the Chinese regulator for its first locally ...

Taiwanese biotech PharmaEssentia (TWSE: 6446) is preparing to seek an expanded US label for its long-acting interferon ...

Germany-based mental health specialist atai Life Sciences is to buy privately-held UK psychedelic drug developer Beckley ...

Japanese biotech Nxera Pharma (TSE: 4565) has received a $15 million payment from Neurocrine Biosciences (Nasdaq: NBIX) after ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved SFL Pharmaceuticals Deutschland’s Aumseqa (aumolertinib) for adults with non-small cell lung cancer (NSCLC).

Detailed results from the Phase III OASIS-4 study have found that Bayer’s elinzanetant showed a statistically significant ...

Positive results from the SERENA-6 Phase III trial have shown that AstraZeneca’s camizestrant alongside a cyclin-dependent ...

US biotech Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced a strategic in-licensing agreement with China’s ...

US drugmaker Protagonist Therapeutics (Nasdaq: PTGX) and Japan’s Takeda Pharma (TYO:4502) announced detailed results from the ...

Swiss generic and biosimilar medicines company Sandoz (SWX: SDZ) today announced that Wyost (denosumab) and Jubbonti ...